NCT01864434

Brief Summary

This study will compare the kinematics data collected from patients with implants created by different manufacturers to see which of these implants provides a more normal-like kinematic pattern compared to the normal knee.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jun 2013

Geographic Reach
1 country

4 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 16, 2013

Completed
13 days until next milestone

First Posted

Study publicly available on registry

May 29, 2013

Completed
3 days until next milestone

Study Start

First participant enrolled

June 1, 2013

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2014

Completed
2 months until next milestone

Results Posted

Study results publicly available

December 24, 2014

Completed
Last Updated

October 10, 2019

Status Verified

October 1, 2019

Enrollment Period

1.4 years

First QC Date

May 16, 2013

Results QC Date

December 15, 2014

Last Update Submit

October 8, 2019

Conditions

Keywords

Knee ProsthesisTotal Knee ArthroplastyCruciate RetainingPosterior Cruciate Retaining

Outcome Measures

Primary Outcomes (3)

  • Kinematics - Deep Knee Bend Activity

    Lateral Anterior Posterior (LAP) and Medial Anterior Posterior (MAP) translations, and Axial Rotation (AR) and maximum flexion of medial femoral condyles during deep knee bend (DKB) activity

    3 months post-operative

  • Kinematics - Ramp up Activity

    Lateral Anterior Posterior (LAP) \[during 3 moments - 0-33%, 33-66% and 66-100%\] and Medial Anterior Posterior (MAP) \[during 3 moments - 0-33%, 33-66% and 66-100%\] translations, and Axial Rotation (AR) \[during 3 moments - 0-33%, 33-66% and 66-100%\] of medial femoral condyles during ramp up activity

    3 months post-operative

  • Kinematics - Ramp Down Activity

    Lateral Anterior Posterior (LAP) \[during 3 moments - 0-33%, 33-66% and 66-100%\] and Medial Anterior Posterior (MAP) \[during 3 moments - 0-33%, 33-66% and 66-100%\] translations, and Axial Rotation (AR) \[during 3 moments - 0-33%, 33-66% and 66-100%\] of medial femoral condyles during ramp down activity

    3 months post-operative

Study Arms (2)

Patients with a Stryker Triathlon CR TKA

Patients implanted with a Stryker Triathlon Posterior Cruciate Retaining Total Knee Arthroplasty.

Device: Stryker posterior cruciat retaining (PCR) total knee arthroplasty (TKA)

Patients with a Zimmer PCR TKA

Patients implanted with a Zimmer NexGen Posterior Cruciate Retaining Total Knee Arthroplasty.

Device: Zimmer PCR TKA

Interventions

The fluoroscopy procedure itself is used as a means of data collection and is not the intervention under investigation; therefore, the study is observational and not interventional.

Also known as: Triathlon PCR TKA
Patients with a Stryker Triathlon CR TKA

The fluoroscopy procedure itself is used as a means of data collection and is not the intervention under investigation; therefore, the study is observational and not interventional.

Also known as: Zimmer NexGen PCR TKA
Patients with a Zimmer PCR TKA

Eligibility Criteria

Age40 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Participants will be patients of Dr. Harold E. Cates of Tennessee Orthopaedic Clinics and must have been implanted with either a Stryker Triathlon CR TKA or Zimmer PCR TKA

You may qualify if:

  • Must be at least 3 months post-operative with no other surgical procedures conducted within the past 6 months
  • Must have body weight of less than 250 lbs
  • Must have Body Mass Index of less than 38
  • Must be judged clinically successful with a Knee Society Score \>90
  • Must have 100% post-operative passive flexion with no ligamentous laxity or pain
  • Must be able to walk on level ground without aid of any kind
  • Must be able to ascend and descend a ramp with a 10 degree incline with no assistance
  • Must be willing to sign both Informed Consent and HIPAA forms
  • Must be between 160 cm (5'3) and 193 cm (6'4) tall

You may not qualify if:

  • Pregnant or potentially pregnant females
  • Unwilling to sign Informed Consent or HIPAA forms

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (4)

Tennessee Orthopaedic Clinic, Tennessee Orthopaedic Foundation for Education & Research

Knoxville, Tennessee, 37923, United States

Location

Dougherty Engineering Building, Room M007

Knoxville, Tennessee, 37996, United States

Location

Perkins Hall, The University of Tennessee

Knoxville, Tennessee, 37996, United States

Location

Science and Engineering Research Facility

Knoxville, Tennessee, 37996, United States

Location

MeSH Terms

Interventions

Polymerase Chain ReactionArthroplasty, Replacement, Knee

Intervention Hierarchy (Ancestors)

Nucleic Acid Amplification TechniquesGenetic TechniquesInvestigative TechniquesArthroplasty, ReplacementArthroplastyOrthopedic ProceduresSurgical Procedures, OperativePlastic Surgery ProceduresProsthesis Implantation

Results Point of Contact

Title
Adrija Sharma, Ph. D.
Organization
University of Tennessee

Study Officials

  • Adrija Sharma, Ph D

    The University of Tennessee

    PRINCIPAL INVESTIGATOR
  • Richard D Komistek, Ph D

    The University of Tennessee

    PRINCIPAL INVESTIGATOR
  • William R Hamel, Ph D

    The University of Tennessee

    PRINCIPAL INVESTIGATOR
  • Harold E Cates, MD

    Tennessee Orthopaedic Clinics

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

May 16, 2013

First Posted

May 29, 2013

Study Start

June 1, 2013

Primary Completion

November 1, 2014

Study Completion

November 1, 2014

Last Updated

October 10, 2019

Results First Posted

December 24, 2014

Record last verified: 2019-10

Locations